FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 41 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $99,457 | -1.7% | 8,944 | -0.8% | 0.00% | – |
| Q4 2023 | $101,204 | +48.8% | 9,020 | -0.4% | 0.00% | – |
| Q3 2023 | $68,018 | -11.8% | 9,057 | +3.7% | 0.00% | – |
| Q2 2023 | $77,130 | -2.4% | 8,735 | -31.1% | 0.00% | – |
| Q1 2021 | $79,000 | -16.0% | 12,685 | +0.3% | 0.00% | – |
| Q4 2020 | $94,000 | +20.5% | 12,651 | -1.0% | 0.00% | – |
| Q3 2020 | $78,000 | -29.1% | 12,785 | -3.2% | 0.00% | -100.0% |
| Q2 2020 | $110,000 | +197.3% | 13,210 | +71.3% | 0.00% | – |
| Q1 2019 | $37,000 | -24.5% | 7,710 | +0.9% | 0.00% | – |
| Q4 2018 | $49,000 | -22.2% | 7,639 | -0.8% | 0.00% | – |
| Q3 2018 | $63,000 | -18.2% | 7,697 | +4.3% | 0.00% | – |
| Q2 2018 | $77,000 | – | 7,381 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,056,000 | 0.85% |
| Southpoint Capital Advisors LP | 3,997,214 | $19,386,000 | 0.82% |
| 683 Capital Management, LLC | 971,351 | $4,711,000 | 0.43% |
| Avoro Capital Advisors LLC | 1,105,999 | $5,364,000 | 0.23% |
| Eventide Asset Management | 720,000 | $3,492,000 | 0.12% |
| Granahan Investment Management | 410,932 | $1,993,000 | 0.11% |
| Zebra Capital Management LLC | 17,568 | $85,000 | 0.04% |
| Hartford Financial Management Inc. | 12,300 | $60,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 84,750 | $411,000 | 0.01% |
| Wealthspire Advisors, L.P. | 9,500 | $46,000 | 0.00% |